BioCorRx (BICX) Income towards Parent Company (2016 - 2025)
BioCorRx (BICX) has disclosed Income towards Parent Company for 16 consecutive years, with -$471218.0 as the latest value for Q4 2025.
- Quarterly Income towards Parent Company rose 61.62% to -$471218.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.7 million through Dec 2025, up 48.14% year-over-year, with the annual reading at -$3.5 million for FY2025, 32.68% up from the prior year.
- Income towards Parent Company hit -$471218.0 in Q4 2025 for BioCorRx, down from -$2830.0 in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$2830.0 in Q3 2025 to a low of -$1.6 million in Q1 2021.
- Historically, Income towards Parent Company has averaged -$1.1 million across 5 years, with a median of -$1.1 million in 2021.
- Biggest five-year swings in Income towards Parent Company: crashed 74.44% in 2024 and later skyrocketed 99.81% in 2025.
- Year by year, Income towards Parent Company stood at -$1.2 million in 2021, then increased by 3.96% to -$1.2 million in 2022, then rose by 16.15% to -$969009.0 in 2023, then dropped by 26.69% to -$1.2 million in 2024, then skyrocketed by 61.62% to -$471218.0 in 2025.
- Business Quant data shows Income towards Parent Company for BICX at -$471218.0 in Q4 2025, -$2830.0 in Q3 2025, and -$1.4 million in Q2 2025.